Assessment of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in Ethiopia

Assessment of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in Ethiopia

November 12 2020
30 minutes
Webinar series
Innovations in Hepatitis Elimination (with Clinical Liver Disease)
Video URL

The fourth article in the new "Innovations in Hepatitis Elimination" series is "Assessment of non-invasive markers of liver fibrosis in patients with hepatitis C in Ethiopia." This webinar will feature an interview with two of the authors of the article. The  authors will discuss the motivations and rationale behind their study to validate APRI and FIB-4 as alternatives to liver biopsy and transient elastography in the sub-Saharan African context. They will also describe potential implications of the study for revisiting WHO recommendations for APRI cutoffs for chronic hepatitis C care in sub-Saharan African countries.

Read the article here

CLD Author Interview

 

Contact globalhep [at] taskforce.org for more information

There are no presenters for this webinar.
There are no sponsors for this webinar.